Skip to Main content Skip to Navigation
Theses

Conception, synthèse et dévelopement d'inhibiteurs du répresseur transcriptionnel mycobactérien ETHR selon une approche par fragments. Une nouvelle approche dans la lutte contre la tuberculose

Abstract : Tuberculosis (TB) remains the leading cause of death due to a single infective agent with more than 1.5 million people killed each year. In 2011, the world health organization (WHO) estimated that one third of the world’s population is infected with Mycobacterium tuberculosis, the pathogen responsible for the disease. This phenomenon may be due to an explosive escalation of TB incidence that occurred in the 1980s due to the emergence of both resistant strains and HIV epidemic.In 2000, EthR, a mycobacterial transcriptional repressor, was identified as a key modulator of ethionamide (ETH) bioactivation. ETH is one of the main second-line drugs used to treat drug resistant strains. In 2009, it was shown that co-administration of ETH and drug-like inhibitors of EthR was able to boost ETH activity threefold in a mouse-model of TB-infection, thus validating the target for a new therapeutic strategy.This work deals with the discovery and optimisation of new EthR inhibitors, based on a small molecule, called a “fragment”, co-crystallized with the protein. We combined in silico screening, in vitro evaluation of the hit compounds, study of co-crystal structures and medicinal chemistry to develop three complementary approaches called “fragment growing”, “fragment merging” and “fragment linking” that led to the discovery of very potent inhibitors. Based on these results, we are currently selecting a potential candidate for new in vivo experiments.
Document type :
Theses
Complete list of metadatas

Cited literature [251 references]  Display  Hide  Download

https://tel.archives-ouvertes.fr/tel-01948515
Contributor : Abes Star :  Contact
Submitted on : Friday, December 7, 2018 - 5:35:06 PM
Last modification on : Tuesday, September 15, 2020 - 4:36:27 AM
Long-term archiving on: : Friday, March 8, 2019 - 3:44:25 PM

File

2012LIL2S052.pdf
Version validated by the jury (STAR)

Identifiers

  • HAL Id : tel-01948515, version 1

Collections

Citation

Baptiste Villemagne. Conception, synthèse et dévelopement d'inhibiteurs du répresseur transcriptionnel mycobactérien ETHR selon une approche par fragments. Une nouvelle approche dans la lutte contre la tuberculose. Médecine humaine et pathologie. Université du Droit et de la Santé - Lille II, 2012. Français. ⟨NNT : 2012LIL2S052⟩. ⟨tel-01948515⟩

Share

Metrics

Record views

324

Files downloads

372